AE Wealth Management’s MacroGenics MGNX Stock Holding History

AE Wealth Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-83,156	Closed	-$596K	–	1997
2023 Q1	$596K	Buy	+83,156	New	+$501K	﹤0.01%	1256

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AE Wealth Management's MGNX Position: Q2 2023 in Review

AE Wealth Management sold out of MacroGenics (MGNX) in Q2 2023, closing a stake of 83,156 shares — an estimated $596K sold.

AE Wealth Management first reported a position in MGNX in Q1 2023 and held it in 1 quarter. The position peaked at $596K in Q1 2023. 131 funds tracked by Wall St. Rank hold MGNX as of Q2 2023.

AE Wealth Management reported no remaining MacroGenics position as of Q2 2023 after selling out during the quarter.
AE Wealth Management sold 83,156 MacroGenics shares in Q2 2023, an estimated $596K.
AE Wealth Management first reported a position in MacroGenics in Q1 2023 and held it in 1 quarter.
AE Wealth Management's MacroGenics position peaked at $596K in Q1 2023.
131 funds tracked by Wall St. Rank held MacroGenics as of Q2 2023.

Based on AE Wealth Management's 13F filing for Q2 2023, filed 10 Jul 2023.